Myriad Genetics, Inc. (MYGN) vs Tilray Brands, Inc. (TLRY)

A side-by-side comparison of Myriad Genetics, Inc. and Tilray Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MYGN vs TLRY

growth of $100 · dividends reinvested · last 8y
MYGN -89.3% (-24.4%/yr)TLRY -98.3% (-40.1%/yr)MYGN compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002020202220242026$11$2
MYGN TLRY

MYGN vs TLRY: by the numbers

  • •TLRY is the larger company ($423M vs $404M market cap).
  • •Both run net losses; TLRY's is the smaller (-12.90% vs -13.96% net margin).
  • •TLRY grew revenue faster over the past five years (17.11% vs 9.70% CAGR).

Metrics side by side

Valuation

MetricMYGNTLRY
P/S ratio0.500.37
P/B ratio1.330.26
EV / EBITDAN/A22.89

Profitability

MetricMYGNTLRY
Gross margin68.83%27.57%
Operating margin-12.22%-5.18%
Net margin-13.96%-12.90%
ROE-37.05%-9.23%
ROIC-19.13%-2.98%

Growth (annualized)

MetricMYGNTLRY
Revenue CAGR (5Y)9.70%17.11%
Total return CAGR (5Y)-32.02%-49.30%

Frequently asked

Which has grown faster, MYGN or TLRY?
Over the past five years, TLRY grew revenue faster — MYGN at a 9.70% CAGR versus TLRY at 17.11%.
How have MYGN and TLRY total returns compared?
Over the past 5 years, MYGN delivered -32.02% and TLRY delivered -49.30% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.